BioCardia, Inc. Other Income and Expense
BioCardia, Inc. (BCDA) reported Other Income and Expense of $10.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-12
- BioCardia, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was $10.00K, a 400.00% increase year-over-year.
- BioCardia, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was $7.00K, a 50.00% decline year-over-year.
- BioCardia, Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was $29.00K, a 16.00% increase year-over-year.
- BioCardia, Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was $5.00K, a 73.68% decline year-over-year.
- BioCardia, Inc. nonoperating income (expense) for fiscal 2025 was $50.00K, a 9.09% decline from fiscal 2024.
- BioCardia, Inc. nonoperating income (expense) for fiscal 2024 was $55.00K, a 24.66% decline from fiscal 2023.
- BioCardia, Inc. nonoperating income (expense) for fiscal 2023 was $73.00K.
- BioCardia, Inc. nonoperating income (expense) for fiscal 2022 was -$6.00K, a 185.71% decline from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-12 | $17.00K 10-Q · filed 2026-08-12 | $46.00K derived: sum of 3 quarters · filed 2026-08-12 | $51.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-15 | $36.00K derived: sum of 2 quarters · filed 2026-05-15 | $41.00K derived: sum of 3 quarters · filed 2026-05-15 | $43.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $34.00K derived: sum of 2 quarters · filed 2026-03-24 | $36.00K derived: sum of 3 quarters · filed 2026-08-12 | $50.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-12 | $7.00K derived: sum of 2 quarters · filed 2026-08-12 | $21.00K 10-Q · filed 2025-11-12 | $46.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-12 | $16.00K 10-Q · filed 2026-08-12 | $41.00K derived: sum of 3 quarters · filed 2026-08-12 | $60.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $14.00K 10-Q · filed 2026-05-15 | $39.00K derived: sum of 2 quarters · filed 2026-05-15 | $58.00K derived: sum of 3 quarters · filed 2026-05-15 | $61.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $44.00K derived: sum of 2 quarters · filed 2026-03-24 | $47.00K derived: sum of 3 quarters · filed 2026-03-24 | $55.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-12 | $22.00K derived: sum of 2 quarters · filed 2025-11-12 | $30.00K 10-Q · filed 2025-11-12 | $42.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $3.00K 10-Q/A · filed 2025-10-29 | $11.00K 10-Q/A · filed 2025-10-29 | $23.00K derived: sum of 3 quarters · filed 2025-10-29 | $47.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-14 | $20.00K derived: sum of 2 quarters · filed 2025-05-14 | $44.00K derived: sum of 3 quarters · filed 2025-05-14 | $72.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $36.00K derived: sum of 2 quarters · filed 2025-03-26 | $64.00K derived: sum of 3 quarters · filed 2025-03-26 | $73.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $24.00K 10-Q · filed 2024-11-13 | $52.00K derived: sum of 2 quarters · filed 2024-11-13 | $61.00K 10-Q · filed 2024-11-13 | $51.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $28.00K 10-Q · filed 2024-08-13 | $37.00K 10-Q · filed 2024-08-13 | $27.00K derived: sum of 3 quarters · filed 2024-08-13 | $30.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-14 | -$1.00K derived: sum of 2 quarters · filed 2024-05-14 | $2.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$7.00K derived: sum of 2 quarters · filed 2024-03-27 | -$8.00K derived: sum of 3 quarters · filed 2024-03-27 | -$6.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $3.00K 10-Q · filed 2023-11-08 | $2.00K derived: sum of 2 quarters · filed 2023-11-08 | $4.00K 10-Q · filed 2023-11-08 | $4.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$1.00K 10-Q · filed 2023-08-09 | $1.00K 10-Q · filed 2023-08-09 | $1.00K derived: sum of 3 quarters · filed 2023-08-09 | $3.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $2.00K derived: sum of 2 quarters · filed 2023-05-10 | $4.00K derived: sum of 3 quarters · filed 2023-05-10 | $6.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $2.00K derived: sum of 2 quarters · filed 2023-03-29 | $4.00K derived: sum of 3 quarters · filed 2023-03-29 | $7.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-09 | $4.00K derived: sum of 2 quarters · filed 2022-11-09 | $7.00K 10-Q · filed 2022-11-09 | $516.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.00K 10-Q · filed 2022-08-10 | $5.00K 10-Q · filed 2022-08-10 | $514.00K derived: sum of 3 quarters · filed 2022-08-10 | $514.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-11 | $512.00K derived: sum of 2 quarters · filed 2022-05-11 | $512.00K derived: sum of 3 quarters · filed 2022-05-11 | $513.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $509.00K derived: sum of 2 quarters · filed 2022-03-29 | $510.00K derived: sum of 3 quarters · filed 2022-03-29 | $525.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $1.00K derived: sum of 2 quarters · filed 2021-11-10 | $16.00K 10-Q · filed 2021-11-10 | $50.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-12 | $16.00K 10-Q · filed 2021-08-12 | $50.00K derived: sum of 3 quarters · filed 2021-08-12 | -$515.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-13 | $49.00K derived: sum of 2 quarters · filed 2021-05-13 | -$516.00K derived: sum of 3 quarters · filed 2021-05-13 | -$504.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$531.00K derived: sum of 2 quarters · filed 2021-03-30 | -$519.00K derived: sum of 3 quarters · filed 2021-03-30 | -$496.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$565.00K 10-Q · filed 2020-11-10 | -$553.00K derived: sum of 2 quarters · filed 2020-11-10 | -$530.00K 10-Q · filed 2020-11-10 | -$513.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $12.00K 10-Q · filed 2020-08-13 | $35.00K 10-Q · filed 2020-08-13 | $52.00K derived: sum of 3 quarters · filed 2020-08-13 | $78.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-15 | $40.00K derived: sum of 2 quarters · filed 2020-05-15 | $66.00K derived: sum of 3 quarters · filed 2020-05-15 | $101.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $44.00K derived: sum of 2 quarters · filed 2020-04-09 | $79.00K derived: sum of 3 quarters · filed 2020-04-09 | $115.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | $26.00K 10-Q · filed 2019-11-19 | $61.00K derived: sum of 2 quarters · filed 2019-11-19 | $97.00K 10-Q · filed 2019-11-19 | $134.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-06-30 | $35.00K 10-Q · filed 2019-08-14 | $71.00K 10-Q · filed 2019-08-14 | $108.00K derived: sum of 3 quarters · filed 2020-04-09 | $146.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-03-31 | $36.00K 10-Q · filed 2019-05-15 | $73.00K derived: sum of 2 quarters · filed 2020-04-09 | $111.00K derived: sum of 3 quarters · filed 2020-04-09 | $134.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2017-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $75.00K derived: sum of 2 quarters · filed 2020-04-09 | $98.00K derived: sum of 3 quarters · filed 2020-04-09 | $97.00K 10-K · filed 2020-04-09 |
| 2017-09-30 | $38.00K 10-Q · filed 2018-11-08 | $61.00K derived: sum of 2 quarters · filed 2018-11-08 | $60.00K 10-Q · filed 2018-11-08 | -$50.00K derived: sum of 4 quarters · filed 2019-04-02 |
| 2017-06-30 | $23.00K 10-Q · filed 2018-08-09 | $22.00K 10-Q · filed 2018-08-09 | -$88.00K derived: sum of 3 quarters · filed 2019-04-02 | -$1.66M derived: sum of 4 quarters · filed 2019-04-02 |
| 2017-03-31 | -$1.00K 10-Q · filed 2018-05-10 | -$111.00K derived: sum of 2 quarters · filed 2019-04-02 | -$1.68M derived: sum of 3 quarters · filed 2019-04-02 | -$2.28M derived: sum of 4 quarters · filed 2019-04-02 |
| 2016-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | -$1.68M derived: sum of 2 quarters · filed 2019-04-02 | -$2.28M derived: sum of 3 quarters · filed 2019-04-02 | -$2.70M 10-K · filed 2019-04-02 |
| 2016-09-30 | -$1.57M 10-Q · filed 2017-11-09 | -$2.17M derived: sum of 2 quarters · filed 2017-11-09 | -$2.59M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$600.00K 10-Q · filed 2017-08-14 | -$1.02M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$420.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | -$1.29M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |